Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1990;15:132-139

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Floras, J. S.
Right arrow Articles by Morris, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Floras, J. S.
Right arrow Articles by Morris, B. L.

Hypertension, Vol 15, 132-139, Copyright © 1990 by American Heart Association


ARTICLES

Desipramine blocks augmented neurogenic vasoconstrictor responses to epinephrine

JS Floras, MJ Sole and BL Morris
Division of Cardiology, Toronto General Hospital, Canada.

The forearm vasoconstrictor response to lower body negative pressure (LBNP), a reflex stimulus to norepinephrine release, can be augmented by a prior brachial artery infusion of epinephrine. We wished to determine whether this sustained aftereffect of epinephrine could be replicated by systemic infusion and, if so, whether it could be prevented by prior uptake-1 blockade with desipramine. Eight normal men (mean age 30 years) were studied on two separate study days at least 1 week apart, 2.5 hours after taking, at random, either desipramine (125 mg p.o.) or placebo. Forearm vascular resistance was measured at rest and at the end of 6 minutes of LBNP at -40 mm Hg. This was done both before and 30 minutes after a 60-minute infusion of epinephrine (1.5 micrograms/min i.v.). From similar baselines, the forearm vasoconstrictor response to LBNP was significantly augmented 30 minutes after epinephrine on the placebo day (+17 +/- 4 vs. +12 +/- 3 resistance units, mean +/- SEM, p less than 0.01) but not on the desipramine day (+14 +/- 2 vs. +16 +/- 3 resistance units). The heart rate response to LBNP was also greater after epinephrine on the placebo day (+20 +/- 3 vs. +16 +/- 2 beats/min, p less than 0.05). Mean arterial pressure was higher after epinephrine infusion on the placebo (p less than 0.01) but not on the desipramine day.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. H. H. Leenen, E. Coletta, A. Fourney, and R. White
Aging and cardiac responses to epinephrine in humans: role of neuronal uptake
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2498 - H2503.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Maignan, M. Legrand, I. Aboulfath, M. Safar, and J.-L. Cuche
Norepinephrine kinetics in freely moving rats
Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E726 - E735.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. S. Goldstein, A. Golczynska, J. Stuhlmuller, C. Holmes, R. F. Rea, E. Grossman, and J. Lenders
A Test of the "Epinephrine Hypothesis" in Humans
Hypertension, January 1, 1999; 33(1): 36 - 43.
[Abstract] [Full Text] [PDF]